|
FDA, Health Canada Say Robust Recall Plans Needed
SEATTLE — While the degree of risk and a company’s history dictate the level of regulatory scrutiny a device recall audit gets, recall strategies are expected to document supply chain communications down to the patient, FDA and Health Canada officials say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives